Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02296307

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Sponsor: McGill University

View on ClinicalTrials.gov

Summary

This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

Official title: Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women

Key Details

Gender

FEMALE

Age Range

45 Years - Any

Study Type

OBSERVATIONAL

Enrollment

13600

Start Date

2012-01

Completion Date

2026-01

Last Updated

2024-05-02

Healthy Volunteers

No

Interventions

OTHER

Blood test: CA-125 biomarker

* CA-125 biomarker blood test at visit 1, day 1. * CA-125 biomarker blood test at visit 2, week 6.

OTHER

Second Test: Transvaginal Ultrasound

-Transvaginal Ultrasound at visit 1, day 1.

OTHER

Follow-up phone call

Phone call 6 months after last visit to verify continued health.

Locations (8)

West Island Cancer Wellness Centre

Kirkland, Quebec, Canada

Axion 50 plus

Laval, Quebec, Canada

Clinique Familiale Pas-A-Pas

Montreal, Quebec, Canada

Clinique Médicale du Haut-Anjou

Montreal, Quebec, Canada

McGill University Health Centre, Royal Victoria Hospital

Montreal, Quebec, Canada

Queen Elizabeth Health Centre

Montreal, Quebec, Canada

Lachine Hospital

Montreal, Quebec, Canada

Clinique du Dr. L. Quintal

Saint-Lambert, Quebec, Canada